vanadates has been researched along with Breast Cancer in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (43.75) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Caner, A; Onal, MG | 1 |
| Johnson, KJ; Liu, C; Peck, AR; Rui, H; Schaber, JD; Sjolund, AB; Tran, TH; Utama, FE; Witkiewicz, AK | 1 |
| Biglia, N; Cassoni, P; Castellano, I; Daniele, L; Marchiò, C; Molinaro, L; Montemurro, F; Recupero, D; Righi, A; Risio, M; Sapino, A; Sismondi, P; Viale, G | 1 |
| Kikawa, KD; Kinch, MS; Van Etten, RL; Vidale, DR | 1 |
| Avellanet, YR; Bull, JL; Camara, J; Dagata, RS; Divekar, S; Gilmore, BA; Lahm, M; Martin, MB; Pentecost, E; Pham, T; Pratap, K; Reiter, R; Stoica, A | 1 |
| Kundu, GC; Mahabeleshwar, GH | 1 |
| Ahmed-Belkacem, A; Di Pietro, A; Perez-Victoria, JM; Pozza, A; Sardo, A | 1 |
| Hamburger, AW; Mishra, S | 1 |
| Freiss, G; Vignon, F | 1 |
| Dilts, CA; Ethier, SP; Kokeny, KE; Ridings, JW | 1 |
| Shen, SH; Srikant, CB | 1 |
| Clairvoyant, F; Jallal, B; Knyazev, P; Mossie, K; Schilling, J; Ullrich, A; Vasiloudis, G; Zachwieja, J | 1 |
| Albanell, J; Arribas, J; Baselga, J; Codony-Servat, J; Lopez-Talavera, JC | 1 |
| Agmon-Levin, N; Altevogt, P; Gutwein, P; Krauss, K; Mechtersheimer, S; Oleszewski, M | 1 |
| Epstein, RJ; Gulliford, T; Huang, G; Ouyang, X; Smith, G; Zhang, H | 1 |
| Kovach, JS; Schaid, DJ; Svingen, PA | 1 |
16 other study(ies) available for vanadates and Breast Cancer
| Article | Year |
|---|---|
Inhibition of Plasma Membrane Calcium Pump Influences Intracellular Calcium Signaling Pathways in Breast Cancer.
Topics: Breast Neoplasms; Calcineurin; Calcium; Calcium Signaling; Calmodulin; Cell Membrane; Female; Humans; Vanadates | 2022 |
PTP1B suppresses prolactin activation of Stat5 in breast cancer cells.
Topics: Breast Neoplasms; Carcinoma; Down-Regulation; Drug Synergism; Dual Specificity Phosphatase 3; Enzyme Inhibitors; Female; Humans; Phosphorylation; Prolactin; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatase, Non-Receptor Type 2; Protein Tyrosine Phosphatase, Non-Receptor Type 6; STAT5 Transcription Factor; Tumor Cells, Cultured; Vanadates | 2010 |
Spontaneous and pronase-induced HER2 truncation increases the trastuzumab binding capacity of breast cancer tissues and cell lines.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; DNA, Neoplasm; Enzyme Inhibitors; Female; Flow Cytometry; Humans; In Situ Hybridization, Fluorescence; Pronase; Protein Binding; Receptor, ErbB-2; Trastuzumab; Vanadates | 2013 |
Regulation of the EphA2 kinase by the low molecular weight tyrosine phosphatase induces transformation.
Topics: Breast Neoplasms; Cell Line, Transformed; Cells, Cultured; Chelating Agents; Dose-Response Relationship, Drug; Egtazic Acid; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Epithelial Cells; Gene Expression Regulation, Enzymologic; Humans; Immunoblotting; Isoenzymes; Oligonucleotides, Antisense; Phosphorylation; Phosphotyrosine; Precipitin Tests; Protein Tyrosine Phosphatases; Proto-Oncogene Proteins; Receptor, EphA2; Signal Transduction; Time Factors; Transfection; Tumor Cells, Cultured; Tyrosine; Vanadates | 2002 |
Estrogen-like activity of metals in MCF-7 breast cancer cells.
Topics: Animals; Breast Neoplasms; Cell Division; Chromium; Cobalt; Copper; COS Cells; Estrogen Receptor alpha; Estrogens; Gene Expression; Humans; Lead; Mercury; Metals, Heavy; Nickel; Proteins; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; Tin; Trefoil Factor-1; Tumor Cells, Cultured; Tumor Suppressor Proteins; Vanadates | 2003 |
Tyrosine kinase p56lck regulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through tyrosine phosphorylation of IkappaBalpha following hypoxia/reoxygenation.
Topics: Active Transport, Cell Nucleus; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Nucleus; DNA, Complementary; Enzyme Inhibitors; Genes, Reporter; Humans; Hydrogen Peroxide; Hypoxia; I-kappa B Proteins; Luciferases; Lymphocyte Specific Protein Tyrosine Kinase p56(lck); Microscopy, Fluorescence; Models, Biological; Mutation; NF-kappa B; NF-KappaB Inhibitor alpha; Oxidation-Reduction; Oxygen; Phosphorylation; Plasmids; Precipitin Tests; Promoter Regions, Genetic; Protein Binding; Serine; Signal Transduction; Time Factors; Transfection; Tyrosine; Urokinase-Type Plasminogen Activator; Vanadates | 2003 |
Purification of breast cancer resistance protein ABCG2 and role of arginine-482.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Amino Acid Substitution; Antibodies, Monoclonal; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Breast Neoplasms; Cell Membrane; Cloning, Molecular; DNA Primers; Drug Resistance, Multiple; Female; Humans; Kinetics; Mitoxantrone; Mutagenesis, Site-Directed; Neoplasm Proteins; Recombinant Proteins; Vanadates | 2006 |
Exogenous phosphotyrosine modulates epidermal growth factor receptor tyrosine phosphorylation.
Topics: Breast Neoplasms; Cell Division; Enzyme Activation; Epidermal Growth Factor; ErbB Receptors; Humans; Phosphorylation; Phosphotyrosine; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Tumor Cells, Cultured; Tyrosine; Vanadates | 1993 |
Antiestrogens increase protein tyrosine phosphatase activity in human breast cancer cells.
Topics: Amino Acid Sequence; Binding Sites; Breast Neoplasms; Cell Division; Chromatography, High Pressure Liquid; Epidermal Growth Factor; ErbB Receptors; Estrogen Antagonists; Homeostasis; Humans; Kinetics; Molecular Sequence Data; Phosphorylation; Protein Tyrosine Phosphatases; Receptors, Estrogen; Tamoxifen; Tumor Cells, Cultured; Vanadates | 1994 |
erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line.
Topics: Base Sequence; Blotting, Western; Breast; Breast Neoplasms; Cell Division; Cell Line; DNA Primers; ErbB Receptors; Female; Gene Expression; Genes, erbB-2; Humans; Kinetics; Molecular Sequence Data; Phosphoproteins; Phosphotyrosine; Pleural Effusion; Polymerase Chain Reaction; Protein Tyrosine Phosphatases; Proto-Oncogene Proteins; Receptor, ErbB-2; Receptor, ErbB-3; RNA, Messenger; Tumor Cells, Cultured; Vanadates | 1996 |
Octapeptide somatostatin analog SMS 201-995 induces translocation of intracellular PTP1C to membranes in MCF-7 human breast adenocarcinoma cells.
Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Biological Transport; Breast Neoplasms; Cell Division; Cytosol; Female; GTP-Binding Proteins; Humans; Intracellular Membranes; Intracellular Signaling Peptides and Proteins; Octreotide; Phosphoric Monoester Hydrolases; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein Tyrosine Phosphatases; Tumor Cells, Cultured; Vanadates; Virulence Factors, Bordetella | 1996 |
The receptor-like protein-tyrosine phosphatase DEP-1 is constitutively associated with a 64-kDa protein serine/threonine kinase.
Topics: Adenosine Triphosphate; Amino Acid Sequence; Breast Neoplasms; Cell Line; Cloning, Molecular; Conserved Sequence; Female; Humans; Kinetics; Molecular Weight; Phosphoproteins; Phosphorylation; Protein Serine-Threonine Kinases; Protein Tyrosine Phosphatases; Receptor-Like Protein Tyrosine Phosphatases, Class 3; Recombinant Proteins; Transfection; Tumor Cells, Cultured; Vanadates | 1997 |
Cleavage of the HER2 ectodomain is a pervanadate-activable process that is inhibited by the tissue inhibitor of metalloproteases-1 in breast cancer cells.
Topics: Breast Neoplasms; Endopeptidases; Humans; Hydroxamic Acids; Metalloendopeptidases; Phenylalanine; Phosphorylation; Protease Inhibitors; Receptor, ErbB-2; Thiophenes; Tissue Inhibitor of Metalloproteinase-1; Tumor Cells, Cultured; Tyrosine; Vanadates | 1999 |
Role of Src kinases in the ADAM-mediated release of L1 adhesion molecule from human tumor cells.
Topics: Animals; Antigens, Surface; Breast Neoplasms; Cell Size; CHO Cells; Cricetinae; Disintegrins; Enzyme Inhibitors; Female; Flavonoids; Humans; Leukocyte L1 Antigen Complex; Membrane Glycoproteins; Metalloendopeptidases; Mice; Neural Cell Adhesion Molecules; Neuroblastoma; Phosphorylation; Protease Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fyn; Recombinant Proteins; Signal Transduction; src-Family Kinases; Tetradecanoylphorbol Acetate; Transfection; Tumor Cells, Cultured; Vanadates | 2000 |
Association of ErbB2 Ser1113 phosphorylation with epidermal growth factor receptor co-expression and poor prognosis in human breast cancer.
Topics: Animals; Antibodies, Monoclonal; Becaplermin; Breast Neoplasms; Cells, Cultured; Colforsin; Epidermal Growth Factor; ErbB Receptors; Fluorescent Antibody Technique; Humans; Immunoblotting; Mice; Microscopy, Confocal; Phorbol 12,13-Dibutyrate; Phosphorylation; Phosphoserine; Platelet-Derived Growth Factor; Prognosis; Proto-Oncogene Proteins c-sis; Receptor, ErbB-2; Transfection; Vanadates | 2001 |
Levamisole potentiation of fluorouracil antiproliferative activity mimicked by orthovanadate, an inhibitor of tyrosine phosphatase.
Topics: Breast Neoplasms; Colonic Neoplasms; Drug Synergism; Ethers, Cyclic; Fluorouracil; Humans; Levamisole; Melanoma; Okadaic Acid; Phosphoric Monoester Hydrolases; Skin Neoplasms; Tumor Cells, Cultured; Tumor Stem Cell Assay; Vanadates | 1992 |